Ultrasound-Guided Erector Spinae Plan Block in Patients Undergoing ESWL

Not Applicable

• Conditions: Urinary System Stones; Pain
• Interventions: Drug: Bupivacaine HCl 0.5 % in 10 ml and 2 % lidocaine in 10 ml; Drug: 5 % Lidocaine Topical Gel and 800 mg ibuprofen intravenously

• Registration Number: NCT04213924
• Lead Sponsor: Ataturk University

Brief Summary

Extracorporeal shock wave lithotripsy (ESWL) is widely used in the treatment of urinary tract stones and is generally applied to outpatients. To achieve fragmentation in ESWL, shock waves must be applied with sufficient power and time. Providing effective analgesia during this procedure is crucial to the success of the procedure. Erector Spinae Plan Block (ESPB) was first described in 2016 and, it is frequently used for postoperative analgesia in urinary system surgery. This study aimed to investigate the efficacy of ESPB in patients undergoing ESWL.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2019-12-27
• Study First Submitted QC: 2019-12-27
• Study First Posted: 2019-12-30
• Status Verified: 2020-06
• Study Start: 2020-06-01
• Last Update Submitted: 2020-06-03
• Last Update Posted: 2020-06-04
• Primary Completion: 2020-09-01
• Study Completion: 2020-10-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• American Society of Anesthesiologist's physiologic state I-II patients undergoing Extracorporeal Shockwave Lithotripsy

Exclusion Criteria

• chronic pain
• bleeding disorders
• renal or hepatic insufficiency
• patients on chronic non-steroidal anti-inflammatory medications
• emergency cases

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Group ESPB	Bupivacaine HCl 0.5 % in 10 ml and 2 % lidocaine in 10 ml	Ultrasound-guided erector spinae plane block with 10 ml %0.5 bupivacaine and 10 ml %2 lidocaine
Group NSAII	5 % Lidocaine Topical Gel and 800 mg ibuprofen intravenously	lidocaine 5% gel and 800 mg ibuprofen intravenously

Primary Outcome Measures

Name	Time	Method
Opioid Consumption	Intraoperative 30 minutes	Opioid consumption during procedure

Secondary Outcome Measures

Name	Time	Method
Visual Analog Pain Score	Intraoperative 30 minutes	Pain will be evaluated with a Visual Analogue Scale (VAS) score of 0-10 (0= no pain and 10= worst imaginable pain)

Trial Locations

Locations (1)

Ataturk University; 🇹🇷 Erzurum, Turkey